These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23495033)

  • 1. Encephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome.
    Duval F; Flabeau O; Razafimahefa J; Spampinato U; Tison F
    Mov Disord; 2013 Sep; 28(10):1464. PubMed ID: 23495033
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination of paroxetine and rasagiline induces serotonin syndrome in a parkinsonian patient.
    Hébant B; Guillaume M; Desbordes M; Gaillon G; Maltête D; Lefaucheur R
    Rev Neurol (Paris); 2016 Dec; 172(12):788-789. PubMed ID: 27838092
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical manifestation of confusion and hallucinations caused by an interaction between rasagiline and escitalopram].
    Bandrés Liso AC; Toyas Miazza C
    Farm Hosp; 2009; 33(3):173-5. PubMed ID: 19712602
    [No Abstract]   [Full Text] [Related]  

  • 4. Triphasic waves in serotonin syndrome.
    Dike GL
    J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):200. PubMed ID: 9048728
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination of Escitalopram and Rasagiline Induced Serotonin Syndrome: A Case Report and Review Literature.
    Suphanklang J; Santimaleeworagun W; Supasyndh O
    J Med Assoc Thai; 2015 Dec; 98(12):1254-7. PubMed ID: 27004312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease.
    Chen JJ; Swope DM; Dashtipour K
    Clin Ther; 2007 Sep; 29(9):1825-49. PubMed ID: 18035186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donepezil and concurrent sertraline treatment is associated with increased hippocampal volume in a patient with depression.
    Suda S; Sugihara G; Suyama R; Mori N; Takei N
    J Clin Psychiatry; 2010 Jun; 71(6):806-8. PubMed ID: 20573331
    [No Abstract]   [Full Text] [Related]  

  • 8. Rasagiline as a therapy for Parkinson's disease (PD).
    Hermanowicz N
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):174-5; author reply 175-6. PubMed ID: 17719520
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy, safety and tolerability of rasagiline as adjunctive therapy in elderly patients with Parkinson's disease.
    Tolosa E; Stern MB
    Eur J Neurol; 2012 Feb; 19(2):258-64. PubMed ID: 21819487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impulse control disorders induced by rasagiline as adjunctive therapy for Parkinson's disease: report of 2 cases.
    Vitale C; Santangelo G; Erro R; Errico D; Manganelli F; Improta I; Moccia M; Barone P
    Parkinsonism Relat Disord; 2013 Apr; 19(4):483-4. PubMed ID: 23305965
    [No Abstract]   [Full Text] [Related]  

  • 11. Motor changes during sertraline treatment in depressed patients with Parkinson's disease*.
    Kulisevsky J; Pagonabarraga J; Pascual-Sedano B; Gironell A; García-Sánchez C; Martínez-Corral M
    Eur J Neurol; 2008 Sep; 15(9):953-9. PubMed ID: 18637826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rasagiline in monotherapy in patients with early stages of Parkinson's disease and in combined and adjunct therapy to levodopa with moderate and advanced stages].
    Pagonabarraga J; Rodríguez-Oroz MC
    Rev Neurol; 2013 Jan; 56(1):25-34. PubMed ID: 23250679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with selective serotonin reuptake inhibitors during pregnancy: deceleration of weight gain because of depression or drug?
    Bodnar LM; Sunder KR; Wisner KL
    Am J Psychiatry; 2006 Jun; 163(6):986-91. PubMed ID: 16741197
    [No Abstract]   [Full Text] [Related]  

  • 14. Serotonin syndrome in a Parkinson disease patient after intake of an ethanol-containing homeopathic medication.
    Suratos CTR; Del Rosario MM; Jamora RDG
    Neurodegener Dis Manag; 2020 Aug; 10(4):219-222. PubMed ID: 32664782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for Parkinson's disease.
    Guay DR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):330-46. PubMed ID: 17296539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin syndrome associated with sertraline monotherapy at therapeutic doses.
    Ozdemir S; Yalug I; Aker AT
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):897-8. PubMed ID: 18077070
    [No Abstract]   [Full Text] [Related]  

  • 17. Sertraline and tic: case report.
    Ghanizadeh A
    Pharmacopsychiatry; 2007 Nov; 40(6):289-90. PubMed ID: 18030654
    [No Abstract]   [Full Text] [Related]  

  • 18. A 61-year-old man with Parkinson's disease.
    Hayes HD
    JAMA; 1996 Jul; 276(2):103-4; author reply 104. PubMed ID: 8656499
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute angle closure glaucoma after sertraline.
    Ho HY; Kam KW; Young AL; Chan LK; Yu EC
    Gen Hosp Psychiatry; 2013; 35(5):575.e1-2. PubMed ID: 23040863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinsonism and elevated lactic acid with sertraline.
    Mendhekar DN; Benuiwal RP; Puri V
    Can J Psychiatry; 2005 Apr; 50(5):301. PubMed ID: 15968847
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.